Blog

The Most Commonly Asked Question Related to Cannabis Cannabis is one of the most searched, discussed, and misunderstood topics online. Every day, people ask questions about marijuana's effects, safety, legality, and medical potential. Let's dig in to these questions and get answers. So, what are the most frequently asked cannabis questions? We analyzed common queries from users, forums, health sources, and educational sites to bring you the top 10 cannabis questions asked—along with clea …

Ohio Marijuana Sales 2025 Updates Ohio’s first full year of adult-use cannabis saw steady revenue, price normalization as supply expanded, and evolving rules on purchase limits and local zoning. Below is a practical, data-minded summary for consumers, operators, and city leaders—with signals to watch through late 2025 and into 2026. Executive Snapshot Sales: Roughly $700M+ in adult-use sales during the first full year. Prices: Average flower settled in the mid-$6/gram range by midsu …

Why More Women Are Getting Into Cannabis Culture Cannabis is no longer a boy’s club. From high-powered CEOs to stay-at-home moms and weekend wellness warriors, more women than ever are embracing weed as part of their lifestyle—and they’re doing it in style. One standout trend? The growing popularity of bongs thoughtfully designed with real women in mind. In this fresh look, we explore the drivers behind this cultural shift and what modern women want from their headshops in 2025 …

Marijuana Rescheduling Law Updates The conversation around federal marijuana rescheduling is heating up in Washington again. A proposal to move cannabis from Schedule I to Schedule III under the Controlled Substances Act could reshape the industry, medical research, and tax policy across the U.S. Key Takeaways Federal marijuana rescheduling to Schedule III is under review in 2025. Could ease research barriers and remove IRS 280E limits on standard deductions. Banking restrictions likely rem …

Why Are Cannabis Stocks So Low in 2025? The Disconnect: Green Gold Industry, Red-Tinged Portfolios The U.S. cannabis industry is raking in billions. Legalization has expanded across states, product innovation is peaking, and consumer demand is stronger than ever. Yet, if you look at your cannabis stock portfolio lately, you’re probably seeing red. You’re not alone. From casual Reddit investors to professional analysts, everyone’s asking: “How can cannabis be booming whil …